Jens Markus Borghardt

Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach

Jens Markus Borghardt, Benjamin Weber, Alexander Staab et al. · British Journal of Clinical Pharmacology · 2015 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Evolution of a mini-scale biphasic dissolution model: Impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics

Kathrin Locher, Jens Markus Borghardt, Kerstin J. Frank et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 33 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +15

Model‐based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation

Jens Markus Borghardt, Benjamin Weber, Alexander Staab et al. · British Journal of Clinical Pharmacology · 2016 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Towards a Quantitative Mechanistic Understanding of Localized Pulmonary Tissue Retention—A Combined In Vivo/In Silico Approach Based on Four Model Drugs

Anneke Himstedt, Clemens Braun, Sebastian G. Wicha et al. · Pharmaceutics · 2020 · 12 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs

Niklas Hartung, Jens Markus Borghardt · PLoS Computational Biology · 2020 · 12 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16